Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
A new device for interstitial cystitis is compared to inactive control to determine if it is
safe and effective. The study lasts approximately 7 weeks with a 19-week follow-up period.